Ali Saeed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ali Saeed has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ahbarah M. Soliman
Department of Chemistry Faculty of Science Omar Al-Mukhtar University 919 El-Bayda Libya
2 shared publicationsAmr El‐Demerdash
Metabolic Biology & Biological Chemistry Department John Innes Centre Norwich Research Park Norwich NR4 7UH UK
2 shared publications- Ehab Abdel-Latif
Department of Chemistry, Faculty of Science Mansoura University Mansoura Egypt
2 shared publications - Abdullah Ahmed Ali Ahmed
Universität Hamburg
1 shared publication Altaf S. Almatari
Department of Chemistry Faculty of Science Mansoura University Mansoura 35516 Egypt
1 shared publicationEhab Abdel‐Latif
Department of Chemistry Faculty of Science Mansoura University 35516 Mansoura Egypt
1 shared publication
Latest Publications
- 25 June 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (7) , e202301870
Synthesis and Molecular Docking of some new Thiazolidinone and Thiadiazole Derivatives as Anticancer Agents
New sets of functionalized thiazolidinone and thiadiazole derivatives were synthesized, and their cytotoxicity was evaluated on HepG2, MCF‐7, HTC‐116, and WI38 cells. The synthetic approach is based on the preparation of 4‐(4‐acetamidophenyl)thiosemicarbazide (4) and their thiosemicarbazones 5 a–e, which are converted to the corresponding thiazoldin‐4‐one compounds 6 a–e upon cyclization with ethyl bromoacetate. The thiadiazole compounds 9 and 12 were obtained by reacting 4‐(4‐acetamidophenyl)thiosemicarbazide with isothiocyanates and/or ethyl 2‐cyano‐3,3‐bis(methylthio)acrylate, respectively. The thiazolidinone compounds 6 c and 6 e exhibited strong cytotoxicity against breast cancer cells, with an IC50 (6.70±0.5 μM) and IC50 (7.51±0.8 μM), respectively, very close to that of doxorubicin (IC50: 4.17±0.2 μM). In addition, the anti‐cancer properties of the tested thiazolidinone and thiadiazole scaffolds were further explored by the molecular docking program (MOE)‐(PDB Code‐1DLS). Compounds 5 d, 5 e, 6 d, 6 e, and 7 have the best binding affinity, ranging from −8.5386 kcal.mol−1 to −8.2830 kcal.mol−1.
- 25 June 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (7) , e202301870
Synthesis and Molecular Docking of some new Thiazolidinone and Thiadiazole Derivatives as Anticancer Agents
New sets of functionalized thiazolidinone and thiadiazole derivatives were synthesized, and their cytotoxicity was evaluated on HepG2, MCF‐7, HTC‐116, and WI38 cells. The synthetic approach is based on the preparation of 4‐(4‐acetamidophenyl)thiosemicarbazide (4) and their thiosemicarbazones 5 a–e, which are converted to the corresponding thiazoldin‐4‐one compounds 6 a–e upon cyclization with ethyl bromoacetate. The thiadiazole compounds 9 and 12 were obtained by reacting 4‐(4‐acetamidophenyl)thiosemicarbazide with isothiocyanates and/or ethyl 2‐cyano‐3,3‐bis(methylthio)acrylate, respectively. The thiazolidinone compounds 6 c and 6 e exhibited strong cytotoxicity against breast cancer cells, with an IC50 (6.70±0.5 μM) and IC50 (7.51±0.8 μM), respectively, very close to that of doxorubicin (IC50: 4.17±0.2 μM). In addition, the anti‐cancer properties of the tested thiazolidinone and thiadiazole scaffolds were further explored by the molecular docking program (MOE)‐(PDB Code‐1DLS). Compounds 5 d, 5 e, 6 d, 6 e, and 7 have the best binding affinity, ranging from −8.5386 kcal.mol−1 to −8.2830 kcal.mol−1.
- 25 June 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (7) , e202400313
Synthesis of Some Novel Thiophene Analogues as Potential Anticancer Agents
The aim of this study involves the synthesis novel thiophene analogues that can be used as anticancer medications through a strategic multicomponent reaction connecting ethyl 4‐chloroacetoacetate (1), phenyl isothiocyanate, and a series of active methylene reagents, including ethyl acetoacetate (2), malononitrile, ethyl cyanoacetate, cyanoacetamide 6a–c, N‐phenyl cyanoacetamide derivatives 13a–c, and acetoacetanilide derivatives 18. This reaction was facilitated by dry dimethylformamide with a catalytic quantity of K2CO3. The resultant thiophene derivatives were identified as 4, 8a–b, 9, 12a–d, 15a–c, and 20a–b. Further reaction of compound 4 with hydrazine hydrate yielded derivative 5, respectively. When compound 1 was refluxed with ethyl 3‐mercapto‐3‐(phenylamino)‐2‐(p‐substituted phenyldiazenyl)acrylate 10a–e in the presence of sodium ethoxide, it produced thiophene derivatives 12a–d. Comprehensive structural elucidation of these newly synthesized thiophene‐analogues was accomplished via elemental and spectral analysis data. Furthermore, the study delves into the cytotoxicity of the newly synthesized thiophenes was evaluated using the HepG2, A2780, and A2780CP cell lines. The amino‐thiophene derivative 15b exhibited an increased growth inhibition of A2780, and A2780CP with IC50 values 12±0.17, and 10±0.15 μM, respectively compared to Sorafenib with IC50 values 7.5±0.54 and 9.4±0.14. This research opens new avenues for developing thiophene‐based anticancer agents.
- 25 June 2024
- Published by Wiley in Chemistry & Biodiversity
- Vol. 21 (7) , e202400313
Synthesis of Some Novel Thiophene Analogues as Potential Anticancer Agents
The aim of this study involves the synthesis novel thiophene analogues that can be used as anticancer medications through a strategic multicomponent reaction connecting ethyl 4‐chloroacetoacetate (1), phenyl isothiocyanate, and a series of active methylene reagents, including ethyl acetoacetate (2), malononitrile, ethyl cyanoacetate, cyanoacetamide 6a–c, N‐phenyl cyanoacetamide derivatives 13a–c, and acetoacetanilide derivatives 18. This reaction was facilitated by dry dimethylformamide with a catalytic quantity of K2CO3. The resultant thiophene derivatives were identified as 4, 8a–b, 9, 12a–d, 15a–c, and 20a–b. Further reaction of compound 4 with hydrazine hydrate yielded derivative 5, respectively. When compound 1 was refluxed with ethyl 3‐mercapto‐3‐(phenylamino)‐2‐(p‐substituted phenyldiazenyl)acrylate 10a–e in the presence of sodium ethoxide, it produced thiophene derivatives 12a–d. Comprehensive structural elucidation of these newly synthesized thiophene‐analogues was accomplished via elemental and spectral analysis data. Furthermore, the study delves into the cytotoxicity of the newly synthesized thiophenes was evaluated using the HepG2, A2780, and A2780CP cell lines. The amino‐thiophene derivative 15b exhibited an increased growth inhibition of A2780, and A2780CP with IC50 values 12±0.17, and 10±0.15 μM, respectively compared to Sorafenib with IC50 values 7.5±0.54 and 9.4±0.14. This research opens new avenues for developing thiophene‐based anticancer agents.
- 1 November 2004
- Published by Elsevier in Journal of Molecular Structure
- Vol. 705 (1-3) , 121-126
Synthesis, spectroscopic and molecular structures investigations of some carboxylated schiff bases
- 1 November 2004
- Published by Elsevier in Journal of Molecular Structure
- Vol. 705 (1-3) , 121-126
Synthesis, spectroscopic and molecular structures investigations of some carboxylated schiff bases